Six things to know:
- The lab is a partnership between Amazon, AstraZeneca, Merck, Pfizer and Teva, according to a news release. Rehovot, Israel has been selected as its international headquarters.
- The lab will be powered by AWS, and produce artificial intelligence and computational ventures to develop new pharmaceutical therapies.
- The facility will include both a wet lab for biomedical research and a cloud-based computational lab.
- The lab will create and invest in startups that develop new technology, treatments and approaches for healthcare.
- Mati Gill, former Teva COO, was appointed CEO of AION Labs. Yair Benita, PhD, former principal scientist at Merck, was named chief technology officer.
- The lab’s budget is set at $9.9 million.
